Intravenous artesunate for severe malaria in travelers, Europe. - Wikidata - awgldk - TriplyDB

Intravenous artesunate for severe malaria in travelers, Europe.

Intravenous artesunate for severe malaria in travelers, Europe.

http://www.wikidata.org/entity/Q35876668

about

Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium.Delayed anemia assessment in patients treated with oral artemisinin derivatives for uncomplicated malaria: a pooled analysis of clinical trials data from Mali.Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine.Severe delayed autoimmune haemolytic anaemia following artesunate administration in severe malaria: a case report.Retrospective study of imported falciparum malaria in French paediatric intensive care units.Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins.Management of imported malaria in Europe.Malaria: an update on current chemotherapy.Treating severe malaria in pregnancy: a review of the evidence Severe imported falciparum malaria among adults requiring intensive care: a retrospective study at the hospital for tropical diseases, London An imported case of severe falciparum malaria with prolonged hemolytic anemia clinically mimicking a coinfection with babesiosis.Management of severe paediatric malaria in resource-limited settings.Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with artesunate, France, 2011-2013 Severe falciparum malaria treated with artesunate complicated by delayed onset haemolysis and acute kidney injury.Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children.Severe falciparum malaria complicated by prolonged haemolysis and rhinomaxillary mucormycosis after parasite clearance: a case report.Clinical illness and outcomes in Nigerian children with late-appearing anaemia after artemisinin-based combination treatments of uncomplicated falciparum malaria.Artesunate treatment of severe pediatric malaria: A review of parasite clearance kinetics and clinical implications.Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia.The prognostic value of schizontaemia in imported Plasmodium falciparum malaria.Advances in the treatment of malaria The role of red blood cell exchange for severe imported malaria in the artesunate era: a retrospective cohort study in a referral centre Artesunate versus quinine in the treatment of severe imported malaria: comparative analysis of adverse events focussing on delayed haemolysis Therapeutic efficacy and effects of artesunate-amodiaquine and artemether-lumefantrine on malaria-associated anaemia in Nigerian children aged two years and under.Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria.Intravascular haemolysis with haemoglobinuria in a splenectomized patient with severe Plasmodium knowlesi malaria.Probucol dramatically enhances dihydroartemisinin effect in murine malaria.Roll out of intraveneous artesunate under named patient programmes in the Netherlands, Belgium and France.Severe malaria in Europe: an 8-year multi-centre observational study.Therapeutic efficacy and effects of artemisinin-based combination treatments on uncomplicated Plasmodium falciparum malaria -associated anaemia in Nigerian children during seven years of adoption as first-line treatments Intravenous artesunate versus intravenous quinine in the treatment of severe falciparum malaria: a retrospective evaluation from a UK centre Novel anti-malarial combinations and their toxicity.Treatment of imported severe malaria with artesunate instead of quinine--more evidence needed?Reversal of multidrug resistance by the anti-malaria drug artesunate in the esophageal cancer Eca109/ABCG2 cell line Intravenous Artesunate Reduces Parasite Clearance Time, Duration of Intensive Care, and Hospital Treatment in Patients With Severe Malaria in Europe: The TropNet Severe Malaria Study.Artesunate to treat severe malaria in travellers: review of efficacy and safety and practical implications.Development of Delayed Hemolytic Anemia After Treatment with Oral Artemether-Lumefantrine in Two Patients with Severe Falciparum Malaria.Delayed Hemolysis After Parenteral Artesunate Therapy for Severe Malaria in Two Returning Canadian Travelers.Antiviral effects of artesunate on polyomavirus BK replication in primary human kidney cells.Haemolytic anaemia after oral artemether-lumefantrine treatment in a patient affected by severe imported falciparum malaria.

P2860

Q21034066-EE4710AF-3961-4CB5-82B7-BF28C1FF11A7 Q30850979-981C9374-EA8B-4F93-B2C2-05074FF5E1CF Q33400434-24EED416-C59A-412A-BCC3-4630EF97B9F9 Q33418146-F34516E7-D62C-4831-A9D7-88444139369E Q33432904-FA013BD0-2CDC-4097-9E07-6F279D8BEAB3 Q33886869-E87D2B1F-EBD3-4622-A0D6-85E9C88D93FD Q34300222-30513C9B-C672-441C-9463-C937DD1916A1 Q34433106-7139776B-C9DC-4DCC-AFCB-78D8DFC7A34A Q34456393-00BA3DF9-6625-44EC-B066-8F43C92E13DA Q34622683-6FC0FD20-1FD2-46F3-8FDE-472A5303C5C6 Q34775196-47B5B2B1-F497-4C3E-A75A-DB4FC1F3DC0B Q35142564-5A6D14B1-F983-4CFE-BFB2-4665900501BE Q35546045-93E37024-914F-4835-B0D7-CACEEF76F3FC Q35750308-5B310F47-3B53-4C6F-8D63-C89FB33F407B Q35821563-A4B555A8-865B-4BF5-ADC9-5C297D619F80 Q35860379-951E217E-2DE9-4301-9733-40A325341091 Q36035590-31949D13-738D-45AD-A8A2-FFFC4841FEA1 Q36277347-6138616A-D626-4199-9FF6-F758CE339739 Q36320224-94815D6D-1268-4EED-BC6B-0DA4AD3CF6B1 Q36372875-13F453ED-4AE4-4E18-9F32-BFA55EFDDB32 Q36404786-225D864D-FE4B-484D-8C4E-7C51279820CF Q36796904-EED78360-04A0-408E-B7AD-759C05D11292 Q37033558-785DBCD1-35D2-468A-AF49-F95269D3478A Q37067888-CB9C461E-D2C5-4F4D-B5C7-887E4DEC713A Q37169837-F9DD7F88-E181-4A91-8C16-9B9A36B24F5E Q37243860-C57B808D-5F86-4142-9A45-E870F60396DB Q37260478-266FA039-116E-4985-8F50-D9B6DAE25522 Q37360307-CF1C5189-504F-4EF9-99D3-93DE3899DF54 Q37618634-4C281B84-FE55-499D-87EF-B8CD2BF19A0E Q37628066-C279EFB9-BDC1-49CF-81B1-26527C4E1C7F Q37726740-CEB72685-E8AD-4048-834F-C2202608A536 Q38203334-A460D725-106A-43FB-B293-62DF5B76777A Q38955711-E61DDC9A-E3EE-4843-B8FC-F33469E4E6D3 Q39067984-C9391EDD-856E-4DE2-B724-4E5102043E71 Q39153213-3749792E-A815-439F-B034-CF8F1937A7E0 Q39232091-97FEE29A-9ED7-4C1D-B1BC-85D360A9447E Q39536124-B6FCE17E-9890-4404-A4AC-92DC7A0D3F32 Q41073549-3185C0C0-1C29-497D-A6A0-C73D2CAB1802 Q41907468-B31BA8B9-7E13-47AA-B9A8-5EBD0A0BD855 Q42268263-B17B39D1-8565-4AE5-B3C7-349FBC5DBC0A

P2860

Intravenous artesunate for severe malaria in travelers, Europe.

http://www.wikidata.org/entity/Q35876668

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Intravenous artesunate for severe malaria in travelers, Europe.

@ast

Intravenous artesunate for severe malaria in travelers, Europe.

@en

type

label

Intravenous artesunate for severe malaria in travelers, Europe.

@ast

Intravenous artesunate for severe malaria in travelers, Europe.

@en

prefLabel

Intravenous artesunate for severe malaria in travelers, Europe.

@ast

Intravenous artesunate for severe malaria in travelers, Europe.

@en

P1433

Q35876668-4CF5EBC2-75C5-4C59-8AEF-5988BC48AD91

P1476

Q35876668-8BD76C29-C509-439E-9695-10EA5B797D55

P2093

Q35876668-0B2D74DD-11E6-46A7-A4DB-3DDB576F7FCB

Q35876668-20699DF2-BE66-4BA9-8207-F46EEA488D72

Q35876668-473C96AE-A0B1-4641-AB41-6A44A9E77D6E

Q35876668-6287D0BD-44DA-4DC3-9C67-C27B2048196E

Q35876668-6BDAD53C-AD2A-48C1-A922-B01EEA9AE6B6

Q35876668-99BCFD74-B9EC-40A9-9367-B4F2BCFB1D26

Q35876668-BB09E90E-8F4A-4E3C-A718-6FEA1CB6AB42

Q35876668-DB954DFC-3386-4FEF-9460-8F12E40A9052

Q35876668-E37F84BD-B1F1-4E1C-B270-0C7A3CE621D7

Q35876668-E626C439-AD39-45DB-8ACB-B1F5DCF98232

P2860

Q35876668-0E31C48C-83A5-4061-9911-3A24D84C5015

Q35876668-0F285E82-45E8-454F-B054-58849CB81185

Q35876668-10355FE2-5DB1-4C5C-9025-066EB9616DC0

Q35876668-106FB410-DCD2-464D-B982-AF040258C7AE

Q35876668-11C9AB70-7E3E-459B-BD31-FA4B452884DF

Q35876668-148D228F-415D-48CE-8C58-798CB0ED34B5

Q35876668-19A95F55-2264-411F-A9FF-A8511AC3ACAD

Q35876668-1FD25331-F876-4780-8E5C-1CBD4F60E2F2

Q35876668-22DA90AA-4F90-4204-B191-AB8551080136

Q35876668-4B73CF57-4572-4D66-9373-840E7CC49713

P304

Q35876668-19C7BFDC-A1DD-410B-9EB1-F095A194821A

P31

Q35876668-0F8E6DB4-4F34-4CF1-B346-4AA65CCA0CC2

P356

Q35876668-9588D31F-AC3E-4CD4-8FE8-9D181F3E9C88

P433

Q35876668-D364C272-79D2-44C2-9247-89E5DFC45D8B

P478

Q35876668-358FFCB0-6DE0-4B02-952D-51C6722F07A0

P577

Q35876668-0BE088FB-0E0F-43A6-9426-4A946EDDF854

P5875

Q35876668-CC171E21-6986-427C-BE3A-45A30B4BC002

P698

Q35876668-840DC7F8-0457-4BCC-AA1E-CBFFD153FC16

P921

Q35876668-87370336-E426-406B-905F-C439E06F8A91

Q35876668-E421FC87-C3CD-4C3A-A3D3-9778555BE900

P932

Q35876668-605F22BC-01CE-4DAC-8A0E-00FF59A5CFC6

P356

P1433

Emerging Infectious Diseases

P1476

Intravenous artesunate for severe malaria in travelers, Europe.

@en

P2093

Annette Kapaun

http://www.w3.org/2001/XMLSchema#string

Behruz Foroutan

http://www.w3.org/2001/XMLSchema#string

Holger Flick

http://www.w3.org/2001/XMLSchema#string

Ida Gjorup

http://www.w3.org/2001/XMLSchema#string

Joachim Richter

http://www.w3.org/2001/XMLSchema#string

Kristine Mørch

http://www.w3.org/2001/XMLSchema#string

Mats Hugo-Persson

http://www.w3.org/2001/XMLSchema#string

Norbert Suttorp

http://www.w3.org/2001/XMLSchema#string

Salih Yürek

http://www.w3.org/2001/XMLSchema#string

Thomas Junghanss

http://www.w3.org/2001/XMLSchema#string

P2860

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial

Detection of cell-drug (hapten)-antibody complexes by the gel test

Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: observations from TropNetEurop and SIMPID Surveillance Data.

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.

Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects

Severe allergic reactions to oral artesunate: a report of two cases.

Clinical experience with intravenous quinine, intramuscular artemether and intravenous artesunate for the treatment of severe malaria in Thailand.

Immune hemolysis-serological and clinical aspects.

One center's experience: the serology and drugs associated with drug-induced immune hemolytic anemia--a new paradigm.

Cardiotoxicity of antimalarial drugs.

P304

771-777

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID1705.101229

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51085870

http://www.w3.org/2001/XMLSchema#string

P698

21529383

http://www.w3.org/2001/XMLSchema#string

P921

P932

3321768

http://www.w3.org/2001/XMLSchema#string